MCLR — Medclair AB Income Statement
0.000.00%
- SEK92.80m
- SEK90.17m
- SEK39.85m
- 64
- 30
- 24
- 31
Annual income statement for Medclair AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | PRESS | ARS | ARS | ARS |
Standards: | — | — | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.31 | 6.33 | 10.7 | 24.9 | 39.9 |
Cost of Revenue | |||||
Gross Profit | 3.58 | 4.26 | 7.52 | 20.4 | 24.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.84 | 8.23 | 23.6 | 29.8 | 42.5 |
Operating Profit | -0.535 | -1.9 | -12.9 | -4.91 | -2.61 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.645 | -2.01 | -13 | -4.99 | -2.77 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.645 | -2.01 | -13 | -5 | -2.79 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.645 | -2.01 | -13 | -5 | -2.79 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.645 | -2.01 | -13 | -5 | -2.79 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.078 | -0.1 | -0.14 | -0.06 | -0.03 |
Dividends per Share |